Report Categories
View AllRecent Articles
View All
ARTNA Artesian posts in line Q3 2025 EPS results shares dip 032 in regular trading
ICCC ImmuCell Corporation shares climb 444 percent after its fourth quarter 2025 earnings release
Why is Mesoblast MESO stock moving today Mesoblast posts 59 EPS miss vs street consensus
Coinbase Global Inc COIN Blockchaincom Launches Bespoke Blockchain Wealth Program for HighNetWorth Investors
Technology Reshaping Healthcare From Sensors to Personalized Medicine
Pure Storage Reports Robust Q1 2027 Performance Shares Decline on Guidance
Tracker Mortgages Regain Popularity Amid Uncertain Rate Outlook Evaluating the Pros and Cons
Gujarat and Tamil Nadu to Establish Common Facilities for Space Manufacturing Boost
Beyond Inc to Reunite Buy Buy Baby with Bed Bath Beyond Through Brand Rights Acquisition
ReadytoDrink Cocktails Continue to Drive Alcohol Industry Growth in 2026
FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers
SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher
AIRO Q4 2025 Earnings EPS Falls Far Short of Estimates Despite Stock Gain
HYMC Q3 2025 Earnings Narrower Loss Surprises Estimates as Company Advances Operations
ProFrac Holding Corp Q4 2025 Earnings EPS Misses Consensus Shares Decline 63
Ellington Credit Company Q1 2026 Earnings EPS Miss Amidst Mixed Credit Markets
Amylyx Pharmaceuticals AMLX Gains 336 as Shares Approach Resistance
Immunocore Holdings IMCR Edges Higher Biotech Resilience in a Challenging Market
Ascentage Pharma AAPG Advances 22 as Biotech Sector Finds Footing
Krystal Biotech KRYS Edges Higher Key Support and Resistance Levels in Focus
National Vision Holdings EYE Hovers Near Flat as Stock Tests Key Support Levels
SOBR Q3 2025 Earnings Net Loss of 144 per Share Amidst Operational Focus
WMB Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Edges Higher
BDX Q1 2026 Earnings EPS Surpasses Estimates with 347 Beat
MNPR Q1 2026 Earnings NarrowerThanExpected Loss Reflects Controlled Spending Stock Edges Higher
Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment
RCB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Bond Price Declines